版本:
中国

BRIEF-Aquinox Pharmaceuticals says Q1 loss per share $0.36

May 9 Aquinox Pharmaceuticals Inc:

* Says Q1 net loss $8.3 million

* Aquinox Pharmaceuticals says plans to provide guidance on top line data availability from leadership 301 trial in early August

* Says top line data from leadership 301 trial is anticipated in 2018

* Q1 loss per share $0.36 Source text:(bit.ly/2pZqDtp) Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐